Awareness about the relationship between cytomegalovirus (CMV) infection and acute renal rejection is very important. Early diagnose of CMV infection can reduce episodes of acute renal rejection. 
Introduction
It is known that cytomegalovirus (CMV) is a common pathogens that affects kidney transplant recipients (1) . If prophylaxis did not start, CMV infection usually occurs in the first month after transplantation. Exposure to the CMV can increase with age and present with positive CMV-IgG antibody. After transplantation, CMV infection can increase mortality and morbidity (2, 3) . Risk of CMV infection increased with administration of immunosuppressive drugs to prevent rejection. The CMV contamination may manifest as infection or disease. Detection of CMV by serology, culture or other techniques without sign and symptom of infection defined as CMV infection. If symptoms such as fever, leucopenia and fever or organ involvements occur, CMV disease is diagnosed.
Objectives
The relationship between CMV infection and rejection is not well proven. Some studies have demonstrated the association of two disease, however, some other could not detect any relationship between two diseases (4). The cause of acute kidney transplant rejection after CMV infection is unknown, but immune modulation after infection can play as a major factor. There are some evidences suggest, CMV infection stimulates the immune system. Some studies indicate that CMV infection can induce upregulation of adhesion molecules on endothelial cell of vessels. This up-regulation can enhance the inflammatory process (5) . In this study we investigated the relationship between CMV infection and acute rejection.
Patients and Methods
Between November 2011 and May 2015, 130 renal allograft recipients were included in this case control study. The patients were divided into two groups: patients group, with CMV disease and control group, without CMV infection. Inclusion criteria were all transplanted patients older than 18 years old with CMV infection (CMV DNA levels more than 2000 copy per milliliters) in the patients group and without CMV infection in the control group. Exclusion criteria were patients had received polyclonal antibodies or experienced any episode of acute rejection. All donor and recipients were CMV seropositive prior transplantation. The kidney transplanted were from cadaver, unrelated or related donors. All patients received triple immunosuppressive therapy including calcineurin inhibitors, prednisolone and mycophenolate mofetil. The CMV disease was suspected according to the present signs and symptoms such as; general manifestations (weakness, fever and leucopenia) and increase in hepatic transaminase or symptoms of respiratory involvement. If CMV infection was suspected, blood sample was taken. CMV disease was diagnosed according to the quantitative CMV polymerase chain reaction more than 2000 copy per milliliters. For all patients with CMV viremia the antimetabolite stopped and treatment began with antiviral agents such as ganciclovir or valganciclovir and continued at least 21 days. CMV induced acute rejection was considered if rejection happened within one month after infection. Allograft rejection suspected if any significant increase of baseline plasma creatinine, after ruling-out other causes of increased creatinine includes cyclosporine toxicity, prerenal and post-renal acute kidney injury. Rejection was diagnosed by transplanted renal biopsy or renal scan. All biopsies reviewed by Banff classification (6) . TC-99m diethylenetriaminepentaacetic acid (DTPA) scintigraphy is one of the method of diagnosing acute rejection. The results of which are comparable to biopsy (7) . Delayed visualization of transplanted kidney, decreased perfusion, decreased and low parenchymal uptake is indicative of transplant rejection.
Ethics issues
The study followed the tenets of the declaration of Helsinki. Informed consent was obtained from all patients. The research was approved by ethics committee of Mashhad University of Medical Sciences.
Statistical analysis
Data were analyzed by SPSS software. Descriptive statistics including mean, frequency, SEM, percentage and analytic statistics including chi-square test, t test and MannWhitney U tests were utilized. P value less than 0.05 was considered as significant level.
Results
In this case-control study, 130 kidney transplant patients were included. Table 1 , shows descriptive statistics, mean duration time of dialysis and cause of end-stage renal disease (ESRD) for the CMV infection group and control group. The mean age of patients in control and CMV groups was 36.16 and 36.91 years, respectively. 37.9% in control group and 39.1% in CMV group were female. Between two groups, the patients' age, duration of dialysis, sex, cause of renal failure were not significantly different. In a group of 66 CMV disease patients the incidence of graft rejection was 36.4%, but in a group of 64 control patients, the incidence of graft rejection was 9.4%. Table 2 shows the relationship between rejection and sex, age, duration of dialysis and cause of renal failure. In this study we found that, these parameters are not associated with transplant rejection.
Discussion
CMV infection is one of the most common and important infection after kidney transplantation and important cause of mortality and morbidity. If prophylaxis against CMV is not started, CMV infection occurs early after kidney transplantation (commonly after first month) (8) . Compared to other organ transplantation, kidney transplantation has the lowest risk for CMV infection (9) . The most common risk factors for CMV infection include use of lymphocyte-depleting agents for induction or rejection therapy, donor-recipient mismatching and co-morbid infection and illness. On the other hand, acute rejection is a major cause of allograft loss, and important predictor of chronic rejection. Acute allograft rejection is defined as an acute decrease in renal function. Commonly acute rejection occurs in the first 6 month after kidney transplantation (9) . In this study, we evaluated the association between CMV infection and acute renal allograft rejection. We concluded that CMV disease is a risk factor for acute allograft rejection in patients with kidney transplantation. Previous studies demonstrated that CMV disease is important risk factor for acute renal allograft rejection. Sagedal et al evaluated 477 kidney transplant patients and demonstrated that CMV disease is a predictor of rejection (10) . Similarly, Toupance et al reported that CMV disease but not viremia, is a major risk factor for acute rejection in renal transplant recipients (11) . However, this relationship has not been established in other studies. For example Michael et al, concluded that, after 5 years follow-up, CMV infection was not a risk factor for acute or chronic rejection (12) . CMV disease can cause dysregulation in immune system. This imbalance in the immune system may increase the risk of transplant rejection. Some studies on animal models found that CMV infection can augment the immune response and accelerated of collagen synthesis too (13) .
Conclusion
The results of our study showed that CMV disease can increase the risk of acute kidney transplant rejection, and factors controlling CMV infection, can reduce episode of acute rejection.
Limitations of the study
This study had two limitations; 1-We had small sample size and suggest new study with large sample size. 2-Acute rejection in some patients but not all of them diagnosed with renal biopsy. We recommend to conduct kidney biopsy for all patients. 
